Model Vasexten (barnidipina) -Third-Generation Dihydropyridine Calcium Channel

Vasexten (barnidipina) third-generation dihydropyridine calcium channel antagonist holds high efficacy standards, improving the tolerability profile, minimizing the typical side effects of this class (peripheral edemas and reflex tachycardia) thanks to its lipophilic structure and formulation in modified-release capsules (unique for its class). Vasexten allows optimal control of the hypertensive patient both as single-agent therapy and in combination with other antihypertensive drugs. On Vasexten Italfarmaco has obtained different and original experimental data about blood pressure control, organ protection in collaboration with head physicians and primary Italian Specialist Centers.